Professor of Ophthalmology, University Mich Medical School
Ophthalmology
Dr. Paul R. Lichter, MD
|
|
Give Review
Paul Lichter works in the field of Ophthalmology. He went to University of Michigan Medical School. He received 6 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACS)", "Whos Who in Medicine and Healthcare", "Fellow (FAAO)" and "Top MD". Paul Lichter has written publications. He has 34 publications published with PubMed. The lastest publication is: 'Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma.' Paul Lichter accepts all Medicare patients.
Publications
- Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma.
- DNA Copy Number Variants of Known Glaucoma Genes in Relation to Primary Open-Angle Glaucoma.
- Payment data and the "me" in medicare.
- Hypothesis-independent pathway analysis implicates GABA and Acetyl-CoA metabolism in primary open-angle glaucoma and normal-pressure glaucoma.
- Visual Field Improvement in the Collaborative Initial Glaucoma Treatment Study.
- Vascular tone pathway polymorphisms in relation to primary open-angle glaucoma.
- Association of CAV1/CAV2 Genomic Variants with Primary Open-Angle Glaucoma Overall and by Gender and Pattern of Visual Field Loss.
- Genome-wide association study and meta-analysis of intraocular pressure.
- The NEIGHBOR Consortium Primary Open-Angle Glaucoma Genome-wide Association Study: Rationale, Study Design, and Clinical Variables.
- Risk of Endophthalmitis and Other Long-Term Complications of Trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS).
- CDKN2B-AS1 Genotype-Glaucoma Feature Correlations in Primary Open-Angle Glaucoma Patients From the United States.
- Clinical characteristics of newly diagnosed primary, pigmentary and pseudoexfoliative open-angle glaucoma in the Collaborative Initial Glaucoma Treatment Study.
- Trends in Use of Ancillary Glaucoma Tests for Patients with Open-Angle Glaucoma from 2001 to 2009.
- GALC Deletions Increase the Risk of Primary Open-Angle Glaucoma: The Role of Mendelian Variants in Complex Disease.
- Association between the use of glaucoma medications and mortality.
- Five-year follow-up Optic disc findings of the Collaborative Initial Glaucoma Treatment Study.
- Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and Other baseline factors.
- Continuing medical education, physicians, and Pavlov: can we change what happens when industry rings the bell?
- Cost-effectiveness.
- Robert N. Shaffer.
- CME, physicians, and Pavlov: can we change what happens when industry rings the bell?
- The investigators' perspective on the Collaborative Initial Glaucoma Treatment Study (CIGTS).
- Variation in optineurin (OPTN) allele frequencies between and within populations.
- Investigation of founder effects for the Thr377Met Myocilin mutation in glaucoma families from differing ethnic backgrounds.
- Mutations in TCF8 cause posterior polymorphous Corneal dystrophy and ectopic expression of COL4A3 by Corneal endothelial cells.
- Converting to SITA-standard from full-threshold visual field testing in the follow-up phase of a clinical trial.
- Glaucoma clinical trials and what they mean for our patients.
- Assessing the need for posterior sclerotomy at the time of filtering Surgery in patients with Sturge-Weber syndrome.
- Septuagenarian's phenotype leads to ascertainment of familial MYOC gene mutation.
- Impact of intraocular pressure reduction on glaucoma progression.
- Expectations from clinical trials: results of the Early Manifest Glaucoma Trial.
- Normal-tension glaucoma history.
- Estrogen pathway polymorphisms in relation to primary open angle glaucoma: an analysis accounting for gender from the United States.
Schools
University Of Michigan Medical School
Presby Med Center
University Mich Med Center
University Of Michigan
Procedures Preformed
- Cataract Removal Surgery
- Conjunctivoplasty
- Coreoplasty
- Glaucoma Surgery
- View All
Conditions Treated
- Age-Related Macular Degeneration
- Anterior Ischemic Optic Neuropathy
- Anterior Scleritis
- Aphakia and Other Disorders of Lens
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
- Whos Who in Medicine and Healthcare
- Fellow (FAAO)
- Top MD
Education
-
UCSF -
University of Michigan Hospitals and Health Centers -
University of Michigan Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1184632895 | |
| NPPES Provider LastName | LICHTER | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 481050714 | |
| NPPES Provider State | MI | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 273.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184632895 |
| Last Name Of The Provider | LICHTER |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Steven M. Archer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victor M. Elner, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mariannette J. Miller-Meeks, MD |
|
|
Dr. Anthony P. Adamis, MD |
|
|
Dr. Lauren L. Harris, MD |
|
|
Dr. Jonathan B. Greene, MD |
|
|
Dr. Maud Jacob, MD |
|
|
Dr. Matthew W. Manry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shannon J. Shan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shreya S. Prabhu, MD |